China Pharma Holdings (CPHI) Total Liabilities (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Total Liabilities came in at $8.1 million in Q1 2026, up 12.04% YoY from $7.2 million in Q1 2025, and down 1.7% on a QoQ basis from $8.3 million in Q4 2025.
China Pharma Holdings (CPHI) Total Liabilities (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Total Liabilities data on file, last reported at $8.1 million in Q1 2026.
- Quarterly Total Liabilities rose 12.04% year-over-year to $8.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.1 million (up 12.04% YoY) and the FY2025 annual result came in at $8.3 million, up 15.69% from the prior year.
- Total Liabilities retreated to $8.1 million in Q1 2026, from $8.3 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $15.7 million in Q1 2022 to a low of $6.9 million in Q2 2024.
- A 5-year average of $9.8 million and a median of $8.3 million in 2025 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities advanced 23.83% — and 2024, when it plunged 39.63%.
- Tracing CPHI's Total Liabilities over 5 years: stood at $13.5 million in 2022, then slumped by 33.2% to $9.0 million in 2023, then retreated by 20.8% to $7.1 million in 2024, then advanced by 15.69% to $8.3 million in 2025, then dropped by 1.7% to $8.1 million in 2026.
- The last three Total Liabilities figures came in at $8.1 million (Q1 2026), $8.3 million (Q4 2025), and $7.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 2.12 Bn |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 | 8.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.12 Mn |
| Dec 31, 2025 | 8.26 Mn |
| Sep 30, 2025 | 7.49 Mn |
| Jun 30, 2025 | 7.30 Mn |
| Mar 31, 2025 | 7.25 Mn |
| Dec 31, 2024 | 7.14 Mn |
| Sep 30, 2024 | 6.94 Mn |
| Jun 30, 2024 | 6.85 Mn |
| Mar 31, 2024 | 7.90 Mn |
| Dec 31, 2023 | 9.01 Mn |
| Sep 30, 2023 | 9.24 Mn |
| Jun 30, 2023 | 11.35 Mn |
| Mar 31, 2023 | 12.69 Mn |
| Dec 31, 2022 | 13.49 Mn |
| Sep 30, 2022 | 13.37 Mn |
| Jun 30, 2022 | 13.89 Mn |
| Mar 31, 2022 | 15.70 Mn |
| Dec 31, 2021 | 16.63 Mn |
| Sep 30, 2021 | 11.33 Mn |
| Jun 30, 2021 | 13.42 Mn |